Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
- PMID: 22895826
- PMCID: PMC7079899
- DOI: 10.1007/s00134-012-2673-2
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
Abstract
Purpose: Despite their controversial role, corticosteroids (CS) are frequently administered to patients with H1N1 virus infection with severe respiratory failure secondary to viral pneumonia. We hypothesized that invasive pulmonary aspergillosis (IPA) is a frequent complication in critically ill patients with H1N1 virus infection and that CS may contribute to this complication.
Methods: We retrospectively selected all adult patients with confirmed H1N1 virus infection admitted to the intensive care unit (ICU) of two tertiary care hospitals from September 2009 to March 2011. Differences in baseline factors, risk factors, and outcome parameters were studied between patients with and without IPA.
Results: Of 40 critically ill patients with confirmed H1N1, 9 (23 %) developed IPA 3 days after ICU admission. Five patients had proven and four had probable IPA. Significantly more IPA patients received CS within 7 days before ICU admission (78 versus 23 %, p = 0.002). IPA patients also received significantly higher doses of CS before ICU admission [hydrocortisone equivalent 800 (360-2,635) versus 0 (0-0) mg, p = 0.005]. On multivariate analysis, use of CS before ICU admission was independently associated with IPA [odds ratio (OR) 14.4 (2.0-101.6), p = 0.007].
Conclusions: IPA was diagnosed in 23 % of critically ill patients with H1N1 virus infection after a median of 3 days after ICU admission. Our data suggest that use of CS 7 days before ICU admission is an independent risk factor for fungal superinfection. These findings may have consequences for clinical practice as they point out the need for increased awareness of IPA, especially in those critically ill H1N1 patients already receiving CS.
Figures
Comment in
-
Invasive pulmonary aspergillosis in the ICU: an emerging disease?Intensive Care Med. 2013 Apr;39(4):790. doi: 10.1007/s00134-012-2809-4. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338571 No abstract available.
-
Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 No abstract available.
Similar articles
-
Invasive pulmonary aspergillosis in the ICU: an emerging disease?Intensive Care Med. 2013 Apr;39(4):790. doi: 10.1007/s00134-012-2809-4. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338571 No abstract available.
-
Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 No abstract available.
-
Overtreating or underdiagnosing invasive pulmonary aspergillosis (IPA) in critically ill H1N1 patients: who is right?Intensive Care Med. 2012 Nov;38(11):1733-5. doi: 10.1007/s00134-012-2677-y. Epub 2012 Aug 16. Intensive Care Med. 2012. PMID: 22895827 No abstract available.
-
Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature.Clin Respir J. 2019 Apr;13(4):202-211. doi: 10.1111/crj.12995. Epub 2019 Mar 18. Clin Respir J. 2019. PMID: 30661296 Review.
-
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.Mycoses. 2022 Feb;65(2):152-163. doi: 10.1111/myc.13410. Epub 2021 Dec 22. Mycoses. 2022. PMID: 34882852 Free PMC article. Review.
Cited by
-
Fungal coinfection/superinfection in COVID-19 patients in a tertiary hospital in Mexico.Biomedica. 2024 Aug 29;44(3):328-339. doi: 10.7705/biomedica.7251. Biomedica. 2024. PMID: 39241240 Free PMC article.
-
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.J Fungi (Basel). 2020 Jun 24;6(2):91. doi: 10.3390/jof6020091. J Fungi (Basel). 2020. PMID: 32599813 Free PMC article. Review.
-
Age difference of patients with and without invasive aspergillosis: a systematic review and meta-analysis.BMC Infect Dis. 2024 Feb 19;24(1):220. doi: 10.1186/s12879-024-09109-2. BMC Infect Dis. 2024. PMID: 38373908 Free PMC article.
-
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis.Microorganisms. 2019 Nov 5;7(11):531. doi: 10.3390/microorganisms7110531. Microorganisms. 2019. PMID: 31694308 Free PMC article.
-
[Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis].Arch Bronconeumol. 2021 Jan;57:11-12. doi: 10.1016/j.arbres.2020.09.012. Epub 2020 Sep 28. Arch Bronconeumol. 2021. PMID: 34629631 Free PMC article. Spanish. No abstract available.
References
-
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009, Influenza Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. - DOI - PubMed
-
- Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336:1006–1009. doi: 10.1136/bmj.39537.939039.BE. - DOI - PMC - PubMed
-
- Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA. 2009;302:1880–1887. doi: 10.1001/jama.2009.1536. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical